SIRPA and liposarcoma: The other TAM marker, SIRPA, was identified in macrophages in 31% of the sarcomas, especially chordoma (71% of the cases), dedifferentiated liposarcoma (77%), angiosarcoma (75%), and well-differentiated liposarcoma (65%) [33].